Glaxo's new doc-pay policy mostly pleases critics
Another veteran of the Big Pharma wars questions the timing of GlaxoSmithKline's decision not to pay physician educators. Such speaking gigs are on the wane, at least in his experience, said Gary Sobelson, MD, a family physician in Concord, New Hampshire.
LATEST NEW HAMPSHIRE ANGLE
Marijuana seller target of robbery